The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals
Search results for: biosimilar
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost
The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
South Korea Okays First Officially Approved Monoclonal Antibody for RA
11 Products Looking for U.S. Marketing Nod
GO! This is ‘My Kind of Town’ for Rheumatology
This November, the Windy City will host some of the world’s most gifted speakers and educators in the field of rheumatology. Mark your calendars now for the ACR/ARHP 75th Annual Scientific Meeting, because there will be no better place to be to learn the state of the art in clinical rheumatology.
Drug UPDATES
Information on New Approvals and Medication Safety
Build a Solid Foundation for Patient Care: 2011 Professional Meetings
You’ve come to rely on the ACR for meeting your professional development needs. Along with the ACR/ARHP Annual Scientific Meeting, the College provides symposia and other courses designed especially for rheumatology health professionals.